文献速递分子诊断临床微生物

多重重组酶聚合酶扩增联合侧流免疫层析条检测碳青霉烯酶基因

Detection of carbapenemase genes by multiplex recombinase polymerase amplification combined with lateral flow immunochromatographic strips.
PubMed 文献 · Clin Chim Acta · 2025-10-17

本研究开发了多重重组酶聚合酶扩增(mRPA)联合侧流免疫层析条(LFS)平台,可同时检测五种碳青霉烯酶基因(blaKPC、blaNDM、blaOXA-48、blaVIM和blaIMP)。验证显示该平台与qPCR相比敏感性98.2%、特异性100%、一致性98.5%,检测限为10² CFU/mL(n=66份临床样本),适用于资源有限和分散医疗场景。

要点

  • mRPA-LFS可同时检测五种碳青霉烯酶基因,检测限10² CFU/mL。
  • 与qPCR相比敏感性98.2%、特异性100%、一致性98.5%。
  • 平台便携、设备要求低,适合基层医院和即时检测场景。

核心结论

  • mRPA-LFS平台可快速同时检测五种碳青霉烯酶基因,适用于资源有限地区的CRE管理。

研究设计与样本

  • 开发多重重组酶聚合酶扩增(mRPA)联合侧流免疫层析条(LFS)平台,通过分子杂交同时检测blaKPC、blaNDM、blaOXA-48、blaVIM和blaIMP,使用66份临床样本验证。

主要发现

  • 与非目标临床菌株无交叉反应。
  • 检测限为10² CFU/mL(n=66份临床样本)。
  • 与qPCR相比敏感性98.2%、特异性100%、一致性98.5%。

关键数值与推荐

  • 检测限10² CFU/mL,敏感性98.2%,特异性100%,一致性98.5%(n=66份临床样本,与qPCR比较)。

临床怎么用

  • 该平台便携且技术要求低,可用于基层医院和即时检测设施,辅助临床决策和抗菌药物精准管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Carbapenem-resistant Enterobacterales (CRE) infections are posing a critical global health threat as their prevalence, multidrug resistance, and mortality rates are all increasing.To address this challenge, we developed a multiplex recombinase polymerase amplification (mRPA) coupled with lateral flow immunoassay strip (LFS) to simultaneously detect five carbapenemase genes (blaKPC, blaNDM, blaOXA-48, blaVIM, and blaIMP) via molecular hybridization. This platform enables rapid, minimal equipments across diverse clinical and community settings.Validation demonstrated no cross-reactivity with non-target clinical strains and a detection limit of 102 CFU/mL (n = 66 clinical samples). Compared to qPCR, the assay achieved 98.2 % sensitivity, 100 % specificity, and 98.5 % concordance. The platform's portability and minimal technical requirements make it suitable for decentralized healthcare settings, including primary hospitals and point-of-care facilities.This multiplex, field-deployable assay provides a critical tool for timely clinical decision-making and precision antimicrobial stewardship in CRE management, particularly in resource-limited regions where conventional molecular diagnostics remain inaccessible.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Hu T, Zhou S, Xing Y, et al. Detection of carbapenemase genes by multiplex recombinase polymerase amplification combined with lateral flow immunochromatographic strips. Clin Chim Acta. 2025. PMID: 41110683. doi:10.1016/j.cca.2025.120672

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。